Showing 1 - 20 results of 5,137 for search '(( free ((c decrease) OR (a decrease)) ) OR ( a ((large decrease) OR (marked decrease)) ))', query time: 0.61s Refine Results
  1. 1
  2. 2
  3. 3

    Dox-inducible expression of HA-MAD1 in colon is sufficient to decrease p53 expression and cause chromosome missegregation. by Sarah E. Copeland (13951506)

    Published 2024
    “…Colors indicate samples from different animals. Large circles show mean of cells from 5 fields of view from a single animal. …”
  4. 4
  5. 5
  6. 6

    Cardamonin inhibited tumor growth and decreased FASN and Raptor. by Peiguang Niu (17044532)

    Published 2025
    “…Cardamonin reduces the protein expression of Raptor, thereby inhibiting the mTORC1-regulated DNL pathway. This leads to a decrease in free fatty acid levels. Subsequently, the reduced levels of free fatty acids inhibit the activity of mitochondrial CPT-1 and induces mitochondrial dependent apoptosis. …”
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Table 1_Decreased neuronal excitability in hypertriglyceridemia hamsters with acute seizures.docx by Qiuyue Shen (20373266)

    Published 2024
    “…</p>Conclusion<p>Hypertriglyceridemic Apoc2<sup>−/−</sup> hamsters exhibited reduced seizure frequency and decreased cortical neuron excitability. The upregulation of ZDHHC14, leading to increased I<sub>A</sub>, may be a crucial mechanism underlying the observed seizure protection.…”
  20. 20

    Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

    Published 2024
    “…<b>c</b> Further addition of bevacizumab to serum samples post-bevacizumab administration significantly decreased VEGF-A121 levels in samples to which 20 and 200 μg/mL bevacizumab was added (ANOVA: <i>p</i> < 0.0001; Dunnett’s multiple comparisons test: +2 μg/mL, <i>p</i> = 0.7096 vs control; +20 μg/mL, <i>p</i> = 0.0107 vs control; +200 μg/mL, <i>p</i> < 0.0001 vs control). …”